– the leading provider of online annual reports to individual and institutional investors.

Emisphere Technologies

Emisphere Technologies, Inc., a biopharmaceutical company, focuses on a delivery of therapeutic molecules or nutritional supplements using its Eligen technology primarily in the United States. Its technology applies to the oral route of administration, as well as other delivery pathways, such as buccal, rectal, inhalation, intra-vaginal, or transdermal.

No investor fact sheets added yet
No responsibility reports added yet

Browse Reports